- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07578831
Comparative Effects of Kendall and Feldenkrais Exercise in Upper Crossed Syndrome
Comparative Effects of Kendall and Feldenkrais Exercise on Pain, Cervical Position Sense, Craniovertebral Angle and Function in Upper Crossed Syndrome
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: iqbal Tariq, phd
- Telefonnummer: 03338236752
- E-Mail: iqbal.tariq@riphah.edu.pk
Studieren Sie die Kontaktsicherung
- Name: Rabiya Noor, phd
- Telefonnummer: 03344355660
- E-Mail: Rabiya.Noor@riphah.edu.pk
Studienorte
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Rekrutierung
- Rabiya Noor
-
Kontakt:
- iqbal Tariq
- Telefonnummer: 03338236752
- E-Mail: iqbal.tariq@riphah.edu.pk
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Male subjects between 20-50 years
- Female subjects between 20-50 years
- Cranio-vertebral angle less than 50 degrees
- Subjects who had been experiencing neck pain for more than 3 months
- Slouched sitting for more than four hours per day
- Usage of handheld devices while reading, working, and travelling
- Pain intensity score between 4 to 10 on NPRS
- NDI>10 scores between 10 and 34
- Tight pectoralis major muscle
Exclusion Criteria:
- Surgeries of the cervical spine within past 1 year
- Surgeries or fracture to the shoulder joint
- Cervical instability
- Cervical Radiculopathy
- Neurological disorders such as cervical spondylosis, spondylolisthesis, disc prolapse and rheumatic disease
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Kendall Exercise Method (KM)
|
Strengthening of deep cervical flexors Procedure: Positioning supine with the chin tucked in and lifting the head for 2 to 8 s.
Stretching of cervical extensors Procedure: Maintaining a sitting posture, with hands on the occipital region, and flexed spine while moving head downwards to stretch cervical extensors.
Strengthening of retractors Procedure: Maintaining an upright posture, keep the resistance band circling with strong support and stretching it with the upper limbs of both sides so that there is full retraction of the scapula
|
|
Aktiver Komparator: Feldenkrais Exercise Method (FM)
|
Shoulder 1 minute (2) Relaxation (2) Lift and lower one shoulder slowly Key Focus Focus on small range of motion and awareness Neck Rolls head from one side to the other gently 1 minute Reduce tension, no strain, smooth motion Ear-to-Shoulder (Static) Lower ear to shoulder, return to center 1 minute Observe full-body involvement Ear-to-Shoulder with Shoulder Lift Alternate ear-to-shoulder and shoulder-to-ear 1 minute Gentle coordination of ]head and shoulder Upper Body Rotation (Step 1) Sit forward on chair; rotate upper body right slightly 6-10 Reps Relaxed turning, observe visual range Eyes Fixed with Body Rotation Fix eyes forward, turn upper body right 6-10 Reps Notice effect of eye fixation on motion
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Neck pain and diability index
Zeitfenster: 6th week
|
The NDI is used to measure functional impairment and pain because to its high reliability and validity. A higher NDI score indicates a more severe impairment; the ten parts of the NDI are rated from zero to fifty. With a maximum score of 50, each item may be assessed on a scale from 0 (no disability) to 5 (total impairment). The maximum possible score for each part is 5. If the first statement is marked as true, the section score is 0, and if the final statement is recorded as true, the score is 5. No neck impairment is considered to exist with a score of 0 4, mild disability from 5-14, moderate disability from 15-24, severe disability from 25-34, and full disability from scores over 34(11). The Neck Disability Index exhibited excellent reliability (ICC = 0.92; [95 % CI: 0.46-0.97]).(27) |
6th week
|
|
Head Repositioning Error Test
Zeitfenster: 6th week
|
The Arc tangent of the distance between the reference and target points divided by the distance between reference point and the laser pointer was considered as HRE.This method was first described by Revel et al.
Each participant performed three trials.
The average amount of three HRE was used for data analysis.
No discomfort or complication was reported by participants after HRE test.
The CVA and HRE were measured by two different physiotherapists.(29)
|
6th week
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Aiman Hameed, MSPT(CP), Riphah International University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Schmerzen
- Neurologische Manifestationen
- Erkrankungen des Bewegungsapparates
- Erkrankungen des Nervensystems
- Muskelerkrankungen
- Neuromuskuläre Manifestationen
- Pathologische Prozesse
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Muskelschwäche
- Nackenschmerzen
- Oculocerebral Hypopigmentationssyndrom Typ Preus
Andere Studien-ID-Nummern
- REC/RCR & AHS/25/0108
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .